Want to join the conversation?
$MRK 2Q15 Q&A: Bristow of BofAML asked about the opportunity in Hep C market and Adam told Hep C market represents a very significant opportunity for Merck. At past, around 100,000 to 120,000 at maximum were treated, but now it’s 170,000 to 200,000. Hep C market remains very attractive and Merck is excited about getting into that market place.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.